Despite a 25% share-value drop for the year, Pulike Biologic...

Despite a 25% share-value drop for the year, Pulike Biological Engineering's overall gain of 14% p.a over half a decade along with its consistent growth trend, commands market respect. Current sell-off could be a potential opportunity if the trend continues.